144571-56-2

Upstream product

• 144548-73-2 <1S-<1α-(4R*,5S*),3α,4β,5α,6α(2E,4R*,6R*),7β>>-1-<4-(acetyloxy)-5-methyl-3-methylene-6-phenylhexyl>-4,6,7-trihydroxy-2,8-dioxabicyclo<3.2.1>octane-3,4,5-tricarboxylic acid, 6-(4,6-dimethyl-6-octenoate), 4,5-dimethyl ester 
• 138682-84-5 zaragozic acid A 
• 142561-97-5 zaragozic acid A trimethyl ester 
• 310903-03-8 (1R,2S,5S,7S,8R,9R)-7-((4S,5R)-4-Acetoxy-5-methyl-3-methylene-6-phenyl-hexyl)-9-((E)-(4S,6S)-4,6-dimethyl-oct-2-enoyloxy)-8-hydroxy-4-oxo-3,6,10-trioxa-tricyclo[5.2.1.0^2,5]decane-1,2-dicarboxylic acid dimethyl ester 

Downstream Products

• 310903-05-0 (1R,2S,5R,7S,8R,9R)-7-((4S,5R)-4-Acetoxy-5-methyl-3-methylene-6-phenyl-hexyl)-9-((E)-(4S,6S)-4,6-dimethyl-oct-2-enoyloxy)-8-hydroxy-3,6,10-trioxa-tricyclo[5.2.1.0^2,5]decane-1,2-dicarboxylic acid dimethyl ester 
• 310903-04-9 (1S,3R,4S,5R,6R,7R)-1-((4S,5R)-4-Acetoxy-5-methyl-3-methylene-6-phenyl-hexyl)-6-((E)-(4S,6S)-4,6-dimethyl-oct-2-enoyloxy)-4,7-dihydroxy-3-(toluene-4-sulfonyloxymethyl)-2,8-dioxa-bicyclo[3.2.1]octane-4,5-dicarboxylic acid dimethyl ester 

Relevant academic research and scientific papers

The squalestatins: Tricyclic 3,4-β-lactone and 3,4-oxetane systems

Squalestatin 3,4-β-lactone-4,5-dimethyl ester (8) was reductively ring-opened to yield squalestatin 3-hydroxymethyl-4,5-dimethyl ester (6) using mild reducing conditions (sodium borohydride). Similarly, squalestatin 3,4-oxetane-4,5-dimethyl ester (10) was

The squalestatins: Inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues

Squalestatin analogues modified at C3 were prepared and evaluated for their ability to inhibit rat liver microsomal squalene synthase in vitro. While the 4,6-dimethyloctenoate ester group at C6 was maintained, a number of modifications to the C3 carboxyli